After finishing at $4.14 in the prior trading day, Aurora Cannabis Inc (NASDAQ: ACB) closed at $4.21, up 1.69%. In other words, the price has increased by $+0.0700 from its previous closing price. On the day, 8496802 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our goal is to gain a better understanding of ACB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.45 and its Current Ratio is at 3.79. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 228.37M and an Enterprise Value of 195.16M. As of this moment, Aurora’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.32 while its Price-to-Book (P/B) ratio in mrq is 0.51. Its current Enterprise Value per Revenue stands at 0.92 whereas that against EBITDA is -0.12.
Stock Price History:
The Beta on a monthly basis for ACB is 2.33, which has changed by -38.72% over the last 52 weeks, in comparison to a change of 29.19% over the same period for the S&P500. Over the past 52 weeks, ACB has reached a high of $11.50, while it has fallen to a 52-week low of $2.84. The 50-Day Moving Average of the stock is 3.6974, while the 200-Day Moving Average is calculated to be 4.8988.
Shares Statistics:
The stock has traded on average 1.42M shares per day over the past 3-months and 5.11M shares per day over the last 10 days, according to various share statistics. A total of 34.53M shares are outstanding, with a floating share count of 15.59M. Insiders hold about 0.88% of the company’s shares, while institutions hold 30.36% stake in the company. Shares short for ACB as of Feb 29, 2024 were 3.55M with a Short Ratio of 2.51, compared to 3.62M on Jan 31, 2024.
Earnings Estimates
Its stock is currently analyzed by 2 different market analysts. On average, analysts expect EPS of -$0.17 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.29, while EPS last year was -$1.47. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.07 and -$1.62 for the fiscal current year, implying an average EPS of -$0.92. EPS for the following year is -$0.32, with 3 analysts recommending between -$0.07 and -$0.73.
Revenue Estimates
4 analysts predict $51.5M in revenue for the current quarter. It ranges from a high estimate of $53.5M to a low estimate of $50.69M. As of the current estimate, Aurora Cannabis Inc’s year-ago sales were $46.86M, an estimated increase of 9.90% from the year-ago figure.
Based on 4 analysts’ estimates, the company’s revenue will be $235.29M in the next fiscal year. The high estimate is $248.29M and the low estimate is $223.1M. The average revenue growth estimate for next year is up 17.30% from the average revenue estimate for this year.
